Clinical Investigation Of The Mitroflow Aortic Pericardial Heart Valve
Completed · Not applicable
Conditions studied: Heart Valve Diseases
In brief
This is a trial to demonstrate the safety and effectiveness of the Mitroflow Aortic Heart Valve when used to replace a diseased or dysfunctional aortic valve or aortic valve prosthesis.
Key facts
- Study ID
- NCT00630916
- Run by
- Sorin Group USA, Inc.
- People needed
- 756
- Starts
- 2003-11-01
- Expected to finish
- 2007-12-01
- Last updated by the study team
- 2011-09-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- The subject is male or female 18 years old or older
- The subject or subject's legal representative is willing to sign the informed consent
- A bioprosthesis is the most suitable alternative for replacement of a dysfunctional or diseased native aortic valve or prosthesis accord gin to the current medical practice for valve selection at the center
- The subject is able to return for all follow-up evaluations for the duration of the study (i.e. geographically stable
You may not qualify if…
- The patient has preexisting valve prosthesis in the mitral, pulmonary or tricuspid position
- The patient requires a double or triple valve replacement
- The patient had a Mitroflow Heart valve during the clinical study but who then had the valve explanted
- The patient has active endocarditis
- The subject is or will be participating in a concomitant research study of an investigational product
- The subject is a minor, intravenous drug user, alcohol abuser, prisoner, institutionalized, or is unable to give informed consent
- The patient has a major or progressive non-cardiac disease that, in the investigator's experience, results in a life expectancy of less than 1 year, or the implant of the device produces an unacceptable increased risk to the patient the patient is pregnant or lactating
Where it is running
- Banner Good Samaritan — Phoenix, Arizona, United States
- The University of Arizona — Tucson, Arizona, United States
- Sharp Memorial Hospital — San Diego, California, United States
- Methodist Hospital — Indianapolis, Indiana, United States
- Heart Center of Indiana — Indianapolis, Indiana, United States
- Johns Hopkins Hospital — Baltimore, Maryland, United States
- St. Joseph's Medical Center — Towson, Maryland, United States
- Mayo Clinic — Rochester, Minnesota, United States
- St. Luke's Hospital — Kansas City, Missouri, United States
- Saint Michael's Med. Center — Newark, New Jersey, United States
- Newark Beth Israel Med Ctr — Newark, New Jersey, United States
- Westchester County Med Ctr — Valhalla, New York, United States
- Providence St. Vincent — Portland, Oregon, United States
- Hershey Medical Center — Hershey, Pennsylvania, United States
- Hospital of the Univ. of PA — Philadelphia, Pennsylvania, United States
- Lankenau Hospital — Wynnewood, Pennsylvania, United States
- Baylor Univ. Medical Center — Dallas, Texas, United States
- Denton Regional Medical — Denton, Texas, United States
- Medical Center of Plano — Plano, Texas, United States
- Sentara Norfolk General Hospital — Norfolk, Virginia, United States
- St. Luke's Medical Center — Milwaukee, Wisconsin, United States
- Foothills Medical Centre — Calgary, Alberta, Canada
- Queen Elizabeth II Health Sciences Centre — Halifax, Nova Scotia, Canada
- Sunnybrook and Women's College Health Sciences Centre — Toronto, Ontario, Canada
- Montreal Heart Institute — Montreal, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.